Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Tyrphostin A9

    • Product Name Tyrphostin A9
    • Alias AG-17
    • Einecs 273-295-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    934477

    Product Name Tyrphostin A9
    Cas Number 109253-39-8
    Molecular Formula C17H13NO3
    Molecular Weight 279.29
    Purity ≥98%
    Appearance Yellow solid
    Solubility DMSO, ethanol
    Storage Temperature -20°C
    Iupac Name 2,5-dihydroxycinnamamide
    Target Tyrosine kinase inhibitor
    Smiles C1=CC=C(C=C1)C=CC(=O)NC2=CC(=C(C=C2)O)O
    Synonyms AG-17
    Application Cell signaling research
    Stability Stable under recommended conditions
    Category Inhibitor

    As an accredited Tyrphostin A9 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Tyrphostin A9 is packaged in a 25 mg amber glass vial, sealed for protection against light and contamination, with clear labeling.
    Shipping Tyrphostin A9 is shipped as a stable, dry solid or dissolved in an appropriate solvent under ambient conditions. It is securely packaged in airtight containers, labeled according to regulatory requirements for laboratory chemicals. Shipping complies with international and local regulations for non-hazardous research chemicals to ensure product integrity and safety.
    Storage Tyrphostin A9 should be stored in a cool, dry place at -20°C, protected from light and moisture. The compound is sensitive to air and light, so it should be stored in a tightly sealed container, preferably under an inert atmosphere. Proper storage ensures stability and prevents degradation, maintaining the chemical's effectiveness for laboratory use.
    Application of Tyrphostin A9

    Applications of Tyrphostin A9 in Industrial Manufacturing

    As a specialized chemical manufacturer, we supply Tyrphostin A9 with batch-level traceability and rigorous in-house validation. This material supports key industrial sectors requiring high-purity tyrosine kinase inhibitors. Below, we outline the main downstream application areas, specifying each sector’s compliance standards, standard formulation ratios, functional process integration, and the primary finished products manufactured with this raw material.

    1. Drug Discovery and Preclinical Small Molecule Screening

    Leading pharmaceutical R&D labs rely on Tyrphostin A9 as a reference inhibitor in kinase pathway studies. Its high selectivity and batch consistency make it the compound of choice for rapid small-molecule compound screening, especially in projects related to signaling transduction mechanisms and cell-based assays. Researchers use it to benchmark new kinase inhibitors at various phases before clinical candidate selection.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients (API)
    • USP General Chapter <1058> Analytical Instrument Qualification
    • OECD Principles of Good Laboratory Practice (GLP)
    • 21 CFR Part 11: Electronic Records for Laboratory Data

    Typical usage ratio

    • Final assay concentrations are typically 1–25 µM, prepared via stock solutions between 1–10 mM in DMSO, further diluted into screening plates as required by assay protocol.

    Downstream process integration

    • Material is dispensed into compound libraries, solubilized and plated in microtiter format, integrated after positive-control selection or hit validation stage, and used during standardization of enzyme and cell phenotype assays.

    Final product types

    • Research-use-only (RUO) compound screening panels
    • Cell-based kinase assay kits
    • Preclinical lead identification systems for pharmaceutical development
    • Validated reference libraries for bioactivity profiling

    2. In Vitro Diagnostic (IVD) Reagent Manufacturing

    Diagnostic reagent producers utilize Tyrphostin A9 as a specific modulator within biochemical detection kits. Its inclusion in IVD formulations supports high-sensitivity tyrosine kinase activity assays, which end-user hospitals and labs employ for cell signaling pathway analysis, research-grade biomarker measurement, and personalized medicine workflows.

    Industry compliance standards

    • ISO 13485:2016 Medical Devices — Quality Management Systems
    • EU IVDR (In Vitro Diagnostic Regulation) 2017/746
    • 21 CFR 820: Quality System Regulation (QSR) for Medical Devices
    • EN ISO 14971: Application of risk management to medical devices

    Typical usage ratio

    • Diagnostic formulations generally specify 5–50 µM concentration depending on substrate turnover and assay detection limit, generally incorporated into enzyme cocktails or substrate buffer solutions at 0.001–0.005% w/v.

    Downstream process integration

    • Material added during batch preparation of lyophilized diagnostic reagent mixtures, or blended in final liquid reagent filling; often paired with proprietary labeling substrates during microplate coating or enzyme pre-mixing.

    Final product types

    • Hospital-grade cell signaling IVD panels
    • Research-grade kinase detection ELISA kits
    • Custom reagent packs for automated immunoassay systems
    • Regulatory-submitted companion diagnostic test kits

    3. Academic Biomedical Research Reagent Supply

    University research supply teams directly source Tyrphostin A9 to enable targeted mechanistic studies in molecular and cellular biology. The material provides functional control in cell signal inhibition experiments, gene expression pathway mapping, and proof-of-concept studies across developmental biology, cancer signaling, and neuroscience labs.

    Industry compliance standards

    • ISO 9001:2015 — Quality Management in research-grade reagent supply
    • NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
    • Association of Biomolecular Resource Facilities (ABRF) best practices for core lab reagent management
    • Relevant Material Transfer Agreements (MTA) compliance

    Typical usage ratio

    • Functional experiments commonly use final working concentrations of 10–30 µM, with stock solutions prepared in DMSO and dosing adjusted per cell type or organism model sensitivity, strictly following peer-reviewed protocol references.

    Downstream process integration

    • Compound is provided in aliquoted form to core facility staff, either dispensed pre-dissolved or as a lyophilized solid, and mixed with cell culture or gene transfer media immediately before experiment setup, typically in microplate or tissue culture format.

    Final product types

    • Custom small-molecule inhibitor panels for laboratory research
    • Cell therapy and organoid pre-screening reagent kits
    • Assay-ready reference compound arrays
    • Validated positive control components for cellular pathway kits

    4. Biotech Tool Compound Synthesis and Screening Panel Formulation

    Specialty biochemical manufacturers use Tyrphostin A9 as a pivotal compound in designing and assembling commercially available kinase inhibitor panels. These panels support contract research organizations (CROs), high-throughput screening labs, and instrumentation providers. Material integrity and batch reproducibility are critical for standardizing the bioactivity and specificity profiles offered by such screening kits.

    Industry compliance standards

    • ISO 17034:2016 — General requirements for the competence of reference material producers
    • ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories
    • Chemical Inventory Management in line with US EPA TSCA and EU REACH for biotech applications
    • Reference material registration for RUO (research use only)

    Typical usage ratio

    • Integrated into multiplex screening panels at standard content of 0.1–5 nmol per vial or well, often provided as 10 µL of 10 mM solution or as pre-dried micro-tube or microplate aliquots.

    Downstream process integration

    • Directly dosed into combinatorial screening plates; dispensed via automated micro-dispensing equipment during panel assembly; subject to batch certification and in-process stability testing prior to shipment to CROs or reference labs.

    Final product types

    • Commercial kinase inhibitor screening panels
    • Rapid profiling kits for instrument calibration
    • Multiplex tool compound libraries for CRO research
    • High-throughput bioassay validation sets

    5. Pharmaceutical Intermediate Processing for High-Purity Inhibitor Synthesis

    Select pharmaceutical chemical operations use Tyrphostin A9 as an intermediate starting material for structural analog synthesis, particularly when developing novel or modified tyrosine kinase inhibitors intended for future therapeutic pipelines. Chemical purity and impurity control are strictly monitored at scale-up and purification stages.

    Industry compliance standards

    • ICH Q11: Development and Manufacture of Drug Substances
    • EU GMP Part II: Basic Requirements for Active Substances Used as Starting Materials
    • Pharmacopeia monographs (if applicable—used as analytical standard in process)
    • FDA cGMP requirements for investigational new drug (IND) intermediates

    Typical usage ratio

    • Employed as a precursor for analog synthesis at input ratios tailored to yield target millimoles; in multi-kilo productions, batch-specific input calculated as a stoichiometric equivalent for each desired kinase inhibitor analog.

    Downstream process integration

    • Material added at initial synthetic step under inert atmosphere; involved in condensation or nitration reactions, then advanced through multi-step purification, recrystallization, and intermediate analytical verification before final API synthesis.

    Final product types

    • Pharmaceutical intermediate compounds
    • New chemical entity (NCE) candidate reference samples
    • High-purity kinase inhibitor analogs for IND applications
    • Analytical reference standards for process development
    Free Quote

    Competitive Tyrphostin A9 prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Tyrphostin A9: A Close Look at a Proven Growth Inhibitor

    Purpose Behind Every Batch: Our Story with Tyrphostin A9

    Every chemical we produce carries a history of repeated trials, careful observation, and hard-earned lessons in both synthesis and quality control. Tyrphostin A9 tells a similar story on our production floor. Known chemically as 2,5-dihydroxycinnamic acid 2-cyano-3-(3,4-dihydroxyphenyl)-N-phenylpropenamide, it stands out among the collection of tyrphostins for its potency in regulating kinases in cellular research. Our commitment to precision—from the selection of raw materials to the monitoring of pH and purity—shapes what leaves our facility.

    We began scaling up Tyrphostin A9 production in response to researchers who asked for a solid and specific tyrosine kinase inhibitor that doesn’t break down on the bench and can tolerate handling in typical academic and industrial environments. A decade back, the main question from research groups involved batch-to-batch consistency; the science cannot move forward unless researchers can trust every tube to behave the same as the last one.

    Product Model and Integrity Standards

    Our labs turn out several grades, but for Tyrphostin A9, the choice almost always settles on a high-purity, research-focused powder. Finished batches test above 98% by HPLC; the minor rest includes trace synthetic byproducts well characterized and minimized at every run. To us, this has never been a side note—as hands-on producers, we see purity as a reflection of process discipline and respect for the downstream work researchers conduct. Stable at ambient conditions for typical short-term lab work, this product stores best at -20°C for those with demanding stability needs.

    Particle form affects dissolving properties, so we control the process to avoid problematic clumping or micro-aggregates. Feedback from protein chemists shaped this practice. Acetonitrile or DMSO readily dissolve the powder, allowing straightforward addition to cell cultures without stubborn residue or clumping at the bottom of a tube. There’s no extraneous dust to interfere with optical measurements, a detail confirmed by spectrometry as well as painstaking visual inspection.

    The Value in Research: Applications Where Tyrphostin A9 Excels

    Tyrphostin A9 primarily draws interest for its selective inhibition of platelet-derived growth factor (PDGF) receptor activity and related roles in blocking the MAPK pathway. Biochemists involved in signal transduction work commonly reach for it, as it moves well between in vitro biochemical assays and cell-based functional screens. In practice, that means researchers can start with isolated protein studies, move into cell lines, and later switch up their conditions or media without worrying about erratic compound behavior.

    Our technical partnerships often give us firsthand feedback on day-to-day lab behaviors, especially related to compound solubility and the way Tyrphostin A9 behaves in serum-rich versus serum-free media. Many kinase inhibitors show erratic stability, but this one maintains a predictable profile even after several freeze-thaw cycles. This stability saves researchers from having to prepare fresh solutions every session. The benefit goes beyond convenience: repeatable handling simplifies investigation into time-dependent cell signaling effects.

    Standing Apart: Tyrphostin A9 in a Crowded Landscape

    Tyrphostin A9 holds a specific position among the broader family of tyrosine kinase inhibitors. Compared to the well-worn AG1296 or AG1478, this molecule’s structure offers a unique selectivity that sharply reduces off-target interactions seen with more broadly acting inhibitors. In everyday lab terms, experiments designed to single out PDGF-dependent pathways often report less background noise and fewer confusing secondary effects.

    We have run concurrent assays against other members of the tyrphostin family; side-by-side cell proliferation and phosphorylation experiments confirm the sharper selectivity curve achieved by Tyrphostin A9—even at submicromolar concentrations. The competitive edge is not only due to its chemical makeup but comes from control at every stage of purification and drying, as even minor contamination leads to variable outcomes in sensitive kinase or cell signaling models.

    Over the last few years, some customers shifted to more recently-identified kinase inhibitors, chasing the promise of broader activity. Yet feedback trends show that where experiments require both strong potency and clean, interpretable cellular data, less becomes more: a focused, legacy inhibitor like Tyrphostin A9 often provides results with greater consistency and reproducibility, reducing the scramble to isolate unexpected findings stemming from broad off-target effects.

    Customization and Analytical Support

    Our approach takes feedback from everyday lab work and feeds it straight into process improvement. For example, a small group of neuroscience customers once encountered trouble with residual moisture content, which increased background variability in long-term cell viability assays. We adapted by extending vacuum drying stages and revising moisture specification protocols. Over months, repeat orders confirmed that this hands-on quality shift produced sharper, more interpretable data in both stem cell and neuroblastoma lines.

    For others working on high-throughput screens, packaging matters as much as purity. Conventional glass vials do the job for most, but individual requests for pre-weighted aliquots in amber tubes gave rise to production line flexibility—minimizing the time compound spends exposed to lab air and light. This flexibility speaks to the evolution inevitable in any chemical plant that cares about how its work intersects with the realities of day-to-day postdoc or technician tasks.

    Each production run comes with supporting analytical data—HPLC chromatograms, trace impurity profiles, and, for complex projects, MS spectra on request. This degree of data sharing is driven by researchers who approached us, frustrated that some sources give only batch numbers with no meaningful chromatography or spectral evidence. While outsourcing labs may shun such transparency to cut costs, we see it as proof that our synthesis and purification retain their edge, year after year.

    Behind the Scenes: Synthesis and Quality at Scale

    Sourcing raw materials locally where possible helps keep inbound variability low. Our Tyrphostin A9 production relies on a careful balance of synthetic precision and scalable purification methods. The upstream chemistry, built around the reaction of 2,5-dihydroxyacetophenone with appropriate aromatic aldehyde components, takes place under close scrutiny for both temperature and addition rate. On days where the batch size changes, so do the conditions; process chemists rotate not just through written procedures but through actual trial-and-error to anticipate where scale-up modifies crystallization behavior.

    Strict QC steps run concurrently with production—no waiting for a finished batch before hunting for deviations. Every operator on the floor, from reactor loading to drying bay, has standing authority to halt the process for an analytical check. Those pauses sometimes cost a day’s output, but over time, they preserve trust for the thousands of researchers counting on our quality.

    One recurring challenge comes from the inescapable difficulty of removing structurally similar side-products. While final HPLC content rarely shifts, we see that even trace impurity spikes can matter to downstream users working with sensitive downstream phosphorylation assays or high-sensitivity fluorescence. Early identification of such byproducts now triggers a rerun, ensuring customers are spared the costlier pain of troubleshooting their experiments from the ground up.

    Field Learnings: Listening to the Researchers

    We spend regular time soliciting feedback, especially from smaller research teams who rely on their own observations rather than broad institutional protocols. One repeated observation: researchers operating on lean budgets often look for ways to stretch every milligram. To help, we include handling tips gained from experience—rapid solvent mixing and minimizing open-vial exposure—to make the most of each delivery, maintaining expected potency in cell assays.

    Stories from the field reinforce practices we’ve put in place for labeling, moisture protection, and documentation. A single missed label—caught only because a sharp-eyed postdoc compared lot numbers—once reminded us to double-check human factors in labeling and packing, not just automated printout calibrations. These fixes may sound basic but make or break the practical value of a specialty compound like Tyrphostin A9.

    Reliability Beyond Production: Logistics and Longevity

    The journey from plant to lab does not end at dispatch. Tyrphostin A9, like many reactive organics, can suffer from heat or moisture exposure during transit. Over the years, we tested and settled on multi-layer foil and polymer packaging for all climate-sensitive products, shipping with clear start-of-life stability data enclosed for each lot. Every shipment includes not just technical paperwork but also a short set of use cases and solvent compatibility notes gathered from the broadest range of labs possible—from medical school research departments to industrial screening facilities overseas.

    Longevity in storage often extends past official expiry dates when stored under truly dry, cold, dark conditions. We still encourage all lab managers to track usage dates and solvent-wetted intervals, as missed expiry of inhibitors can skew experiments—a lesson hardly new, but one often overlooked without rigorous record-keeping.

    Practical Insights for Application

    In cell assay work, Tyrphostin A9 holds its own especially where precise dosing matters. For those running dose-response curves or seeking single-concentration blocks, having a stable, well-purified inhibitor means rapid optimization, not extended troubleshooting to account for variable potency. Organic chemistry groups routinely report manageable, low-intensity odors—no forced venting required, which makes a notable difference in teaching labs or open-plan research spaces.

    Solubility remains a persistent discussion point. Some switching from water-only handling to mixed organic systems find the transition smooth; we recommend DMSO or acetonitrile, with full dissolution typically seen in under two minutes with moderate agitation. Once in solution, the compound keeps its active form long enough for typical multi-hour treatment screens, simplifying multi-well plate work.

    Working with tissue or organotypic slices introduces other challenges. To offset adsorption losses, we provide specific binder caution notes and encourage use in buffered, protein-containing media when feasible. Such pointers come less from literature reviews and more from the recurring troubleshooting efforts that our partners share at conferences and via direct inquiry.

    A Word on Comparisons: Tyrphostin A9’s Edges and Limitations

    It's tempting to treat all kinase inhibitors as interchangeable, especially for basic experiments in undergraduate or early postdoctoral work. The reality looks different on the bench. While other tyrphostins, such as AG1478 or AG490, cover broader receptor ranges, these broaden their effects in unpredictable ways. Tyrphostin A9, by contrast, brings a more restrained, focused inhibition profile—valuable especially for teasing out singular dependencies in tightly controlled cell models.

    Reliance on classical inhibitors, backed by well-published protocols, has always made sense for those chasing reproducibility. Newer compounds sometimes boast higher in vitro potency, but careful observers will note that these often come with tradeoffs in toxicology or broader pathway disruption. By ensuring that Tyrphostin A9’s impurities, solvent residues, and physical characteristics remain tightly controlled, we support work that builds on old results rather than discarding them.

    Looking Forward: Guidance and Collaboration

    Having worked nearly two decades refining this specialty, it's clear that communication does not end once the product ships. Our staff keeps regular contact with university groups and biotech startups to gather lessons from successes and failures both, constantly reviewing process logs when edge cases arise. We encourage customers to reach out with experiment details, unexpected observations, or requests for technical files beyond what ships as standard.

    Where users innovate—combining Tyrphostin A9 with new imaging probes, or using it in systems biology screens—our duty is to listen and adapt production. Projects that push the boundaries of dose limits or stability under harsh assay conditions often bring new process tweaks on our end. By keeping these cycles short, innovation from the field drives quality and reliability at scale.

    Ethics and Sustainability

    As the chemical supply chain faces increasing scrutiny on both its sustainability and documentation, we handle raw material sourcing using trusted networks—favoring local or regionally vetted producers whenever possible. Each solvent, each precursor, gets logged for regulatory and sustainability audits. Waste minimization procedures come from years of tweaking—using closed reaction vessels and recovery protocols to cut down on both chemical consumption and the environmental footprint of our operations.

    Every supplier faces cost pressures, and specialty inhibitors come with their own pricing volatility. We aim for transparency when shifts in raw cost affect supply, giving research partners ample warning to plan ahead.

    Final Thoughts: Tyrphostin A9 in Today’s Scientific Landscape

    Making Tyrphostin A9 is more than meeting a catalog specification. Our operators and chemists, working directly with university, medical, and commercial labs, see a living process—one that moves in step with changing research trends, new cell models, and emerging analytical technologies. Each cycle of feedback sharpens both our process and our understanding of what science needs from a specialty supplier.

    Thanks to a strong production foundation, flexibility, and commitment to scientific transparency, Tyrphostin A9 continues to meet the evolving needs of biochemical research. Whether aiming for mechanistic cell pathway clarification or exploring applications in regenerative and cancer biology, the product stands ready as a reliable partner in discovery, grounded in decades of direct production experience and ongoing collaboration with researchers worldwide.